TSRI News

Nature's Own Medicine for Vision Loss: Inhibitor of Angiogenesis Found by TSRI Biologists
A potentially potent inhibitor of angiogenesis, the process whereby new blood vessels are formed from existing ones, can be found in one of the very molecules involved in the same process. This finding, made by two scientists from TSRI, may lead to new therapies, as abnormal angiogenesis is the leading cause of vision loss in the United States.

Cancer Affinity Group Brings Together Basic Researchers and Physicians
TSRI's Cancer Affinity Group promotes intellectual enrichment, scientific discussion, and exchange of ideas among the region's scientists and clinicians.

TSRI Trustee Inducted into the National Inventors Hall of Fame
Herb Boyer, a member of The Scripps Research Institute (TSRI) Board of Trustees, was recently inducted into the National Inventors Hall of Fame, which celebrates the creative and entrepreneurial spirit of great inventors.

Death Called a River

Investigator Dennis Burton at TSRI studies a number of viruses, including the Ebola virus. "The virus is intriguing because it acts so quickly," Burton says. "It kills people in two weeks or less."

Dynamic Actin

Of Molecules and Methods

Catching a Heart Disease Before it Happens

Crucial Genetic Diversity Enzyme Long Sought by Biologists Discovered by Scientists at The Scripps Research Institute

Vision Researcher Keeps Patients in Focus

Novel Amino Acids Come of Age

Molecules caught in the act—TSRI scientists solve elusive enzyme intermediates

A Hard Boiled Look at Metastatic Remodeling Molecules